Independence, along with the Blue Cross Blue Shield Association, and 18
other Blue Cross and Blue Shield (BCBS) companies announced a partnership with
the nonprofit Civica Rx (Civica, Inc.) to form a new company that intends
to lower prices of select high-cost generic drugs.
It is expected that the first generic medications will be available for
individuals and families by early 2022. The new partners welcome further
participation from others in the health care industry who are united with their
goal of promoting competition to spur production of affordable, quality
medication.
To read more about the partnership, visit the BCBS website.
Independence Blue Cross is an independent licensee of the
Blue Cross and Blue Shield Association.